← Back to Clinical Trials
Recruiting NCT06721377

NCT06721377 Evaluation of Different Attachments on Implant-Retained Mandibular Overdenture.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06721377
Status Recruiting
Phase
Sponsor Al-Azhar University
Condition Edentulism in Lower Jaw
Study Type INTERVENTIONAL
Enrollment 10 participants
Start Date 2023-09-01
Primary Completion 2024-12-01

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age 69 Years
Study Type INTERVENTIONAL
Interventions
Novaloc attachmentEquator attachment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 10 participants in total. It began in 2023-09-01 with a primary completion date of 2024-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Patients will be selected from the outpatient clinic of Removable Prosthodontic Department. Faculty of Dental Medicine for Girls, Al-Azhar University.. Each patient will be assessed for eligibility and Informed consent will be obtained from patient after explanation of the treatment protocols and expected outcomes or alternative management.

Eligibility Criteria

Inclusion Criteria: * All patients' ridges should be covered with firm mucosa which is free from any signs of inflammation or ulceration. * Patients should be free from any bone disorder and exhibit adequate height and width of the residual alveolar ridge. * All patients must have sufficient inter arch space. Exclusion Criteria: * Patients with oral or systemic diseases. * Patients with xerostomia or excessive salivation. * Patients with parafunctional habits (bruxism or clenching). * Heavy smoker or alcoholic patients. * Patients with history of temporo-mandibular dysfunction. * Patients with brain disorders or psychiatric disorders.

Contact & Investigator

Central Contact

Sara H Kadry, masters

✉ Sarra.kadry@miuegypt.edu.eg

📞 02-01226595217

Principal Investigator

sara H kadry, masters

PRINCIPAL INVESTIGATOR

Frequently Asked Questions

Who can join the NCT06721377 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, up to 69 Years, studying Edentulism in Lower Jaw. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06721377 currently recruiting?

Yes, NCT06721377 is actively recruiting participants. Contact the research team at Sarra.kadry@miuegypt.edu.eg for enrollment information.

Where is the NCT06721377 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT06721377 clinical trial?

NCT06721377 is sponsored by Al-Azhar University. The principal investigator is sara H kadry, masters. The trial plans to enroll 10 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology